- Home
- MIRM vs EPAM Comparison
MIRM vs EPAM Comparison
Compare MIRM & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | EPAM |
|---|---|---|
| Founded | 2018 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 5.9B |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | MIRM | EPAM |
|---|---|---|
| Price | $93.42 | $113.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | $119.85 | ★ $196.21 |
| AVG Volume (30 Days) | 456.7K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ 3.49 |
| Revenue | $19,138,000.00 | ★ $1,450,448,000.00 |
| Revenue This Year | $26.22 | $8.30 |
| Revenue Next Year | $22.04 | $7.17 |
| P/E Ratio | ★ N/A | $33.55 |
| Revenue Growth | N/A | ★ 25.02 |
| 52 Week Low | $63.23 | $73.06 |
| 52 Week High | $130.00 | $222.53 |
Technical Indicators
Market Signals| Indicator | MIRM | EPAM |
|---|---|---|
| Relative Strength Index (RSI) | 38.75 | 51.88 |
| Support Level | $88.08 | $111.24 |
| Resistance Level | $98.03 | $121.53 |
| Average True Range (ATR) | 3.82 | 4.15 |
| MACD | -0.03 | -0.77 |
| Stochastic Oscillator | 1.32 | 17.40 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.